English
Deutsch
Français
Nederlands
Español
Reset. Heal. Grow.
What a Glitchy Phone Taught Me About Presence, Patience, and Real Healing
The other morning my phone stopped recognizing my face. Nothing dramatic — just a small software hiccup that meant every time I wanted to open it, I had to punch in a four-digit code. Two seconds, tops. And yet I caught myself huffing at the screen like it had personally insulted me. That reaction stopped me cold. When did two seconds become unbearable? And more importantly — what does that little flash of irritation have to do with the deeper work so many of us are trying to do around trauma, addiction, and the constant low-grade restlessness of modern life? Turns out, quite a lot. Because the same nervous-system pattern that makes a broken Face ID feel intolerable is the exact pattern that psychedelic ceremonies, meditation retreats, and master plants keep trying to loosen. Here's the thing about modern convenience: it's quietly training us. Every one-click checkout, every instant reply, every AI answer that appears before we've finished typing — all of it rewires our expectations. Yesterday's miracles become today's baseline, and anything slower than instant starts to feel like an insult. My grandmother grew up carrying buckets of water more than a mile from the village well. My mother waited a full year to see her favorite movie on television. I still remember dropping off film to be developed and returning three days later, hoping the shots weren't blurry. Now I get annoyed if a video buffers for four seconds. None of this is a moral failing. It's just what happens when a nervous system built for slow rhythms gets plugged into a machine that runs on milliseconds. The friction that used to be woven into daily life — the walking, the waiting, the wondering — has been sanded down to almost nothing. And with it, a certain muscle we didn't know we needed has quietly atrophied. Psychologists have a name for that muscle: distress tolerance. It's your capacity to sit with uncomfortable feelings — boredom, anxiety, craving, sadness, agitation — without immediately reaching for something to make them stop. Scroll the feed. Pour the drink. Order the thing. Change the subject. Low distress tolerance is one of the most consistent threads running through the research on anxiety, depression, disordered eating, and substance use. When we can't stay with discomfort, we grab whatever tool is closest to make it go away. Over years, those grabs harden into habits, and those habits harden into the exact stuck patterns that eventually drive people to consider a plant medicine retreat in the first place. This matters more than it sounds. Almost everyone I've met in ceremony — whether they came for ayahuasca, ibogaine, psilocybin, or San Pedro — was, on some level, coming to sit with something they'd been running from for a long time. The medicine doesn't do the work for you. It just makes it very, very hard to run. Sitting with my glitchy phone, I started to notice something under the annoyance. Impatience isn't really about time. It's a subtle rejection of what's actually happening. It's the mind reaching forward into a different moment, refusing to relax into the one that's here. Which is exactly what the master plants tend to point at. Anyone who's sat through a long ayahuasca ceremony knows there comes a moment — often around hour three, when the shipibo icaros feel like they'll never end and your knees are aching and your mind is looping — where you finally give up trying to make the experience be something else. You stop wanting it to be over. And in that surrender, something shifts. The teacher in the maloca and the teacher in the broken Face ID are pointing at the same door. One is louder. One is louder for a reason. But the invitation is identical: can you stop wrestling this moment into a different shape and just be here for it? I decided to run a small experiment. Instead of getting the Face ID fixed right away, I let it stay broken for a while. Every time I picked up the phone and had to enter the code, I'd take one intentional breath. Just one. Feel my feet on the floor. Notice where I actually was. Something interesting happened. The irritation didn't vanish, but it got quieter. And I started noticing similar micro-invitations everywhere: Each of these tiny frictions used to feel like an obstacle. Now they started feeling like a bell — the kind Zen practitioners ring to call the mind home. A little chime saying: here, right now, is your practice. People often ask me what integration actually looks like after a psychedelic retreat. They imagine it must involve elaborate rituals, dieta continuations, altars, hours of journaling. Sometimes, sure. But most of the meaningful integration I've seen — and lived — happens in exactly these small moments. The ceremony cracks something open. It shows you, undeniably, that another way of being is possible. That the tight, hurried, reactive version of yourself is not the whole story. But then you go home. And the phone is still there. The traffic is still there. The old patterns are still there, patient as hell, waiting to reabsorb you. Integration is what happens in the space between stimulus and response. It's the ten seconds when you notice the craving, or the irritation, or the urge to numb out — and instead of acting on it, you breathe. You stay. You let the wave rise and fall without feeding it. That's the same skill the medicine was teaching you in ceremony. It just doesn't come with the drums and candles this time. For anyone recovering from addiction — whether to substances, screens, work, food, or the endless dopamine drip of the internet — this is where the actual freedom is built. Not in one big breakthrough. In a thousand small refusals to grab the exit. You don't need a broken phone to practice this, but you also don't need to wait for your next retreat. A few things that have helped me and the people I've sat with: None of this is glamorous. That's kind of the point. Real change tends to look boring from the outside — and feel, from the inside, like slowly getting your life back. A few days into my experiment, I restarted the phone for an unrelated reason, and Face ID came back to life. My first reaction genuinely surprised me: disappointment. The broken thing had become a small teacher, and I wasn't quite ready to let it go. Every irritation carries this potential. Every urge to speed up is also an invitation to slow down. Every small frustration is a rehearsal for the bigger ones — the grief, the cravings, the dark nights that plant medicine work tends to surface and ask you to meet. The muscle you build waiting for a phone to unlock is the same muscle that helps you stay with what arises in ceremony, and in the months after. If any of this resonates, and you're feeling pulled toward doing this work more deeply, a range of curated ayahuasca, psilocybin, and plant-medicine retreats can be browsed on our marketplace here. Take your time with the decision. The right one is worth waiting for — and honestly, learning to wait well might be the first ceremony.
Transpersonal Therapy Explained: A Psychospiritual Path for Deep Healing
Somewhere between the therapist's couch and the ceremonial mat sits a therapeutic tradition most people have never heard of. It's called transpersonal therapy, and if you've ever come out of a meditation, a psychedelic ceremony, or a moment of raw grief feeling like something bigger than your ordinary self was in the room — this is the corner of psychology that takes that experience seriously. For readers weighing an ayahuasca retreat, a psilocybin session, or any encounter with the master plants, understanding transpersonal therapy matters. It's often the framework a good integration therapist is quietly using, whether they name it or not. And in a moment when psychedelic healing is going mainstream, knowing the shape of the therapeutic container around it is genuinely useful information. Transpersonal therapy is a form of psychotherapy that treats spiritual, existential, and meaning-making experiences as legitimate psychological material — not symptoms to be medicated away, not woo to be tolerated politely. It grew out of humanistic psychology in the 1960s and 70s, when a handful of researchers started asking what psychology was missing by only studying pathology. Abraham Maslow's work on peak experiences opened one door. Stanislav Grof's early LSD research and later development of holotropic breathwork opened another. Together, they helped carve out room in mainstream psychology for the parts of human experience that don't fit inside a cognitive-behavioral worksheet — mystical states, ego dissolution, ancestral memory, the sense of being connected to something larger than the individual self. It's worth separating two things that sound similar. Transpersonal psychology is the broader academic field — the research side. Transpersonal therapy is what happens in the consulting room when a practitioner applies those ideas to actual clients. Not every transpersonal psychologist sees clients, and plenty of therapists who explore spirituality with their clients don't use the label. Regular therapy tends to focus on symptoms, cognitions, and behavior — measurable stuff you can chart on a graph. That's valuable. But if you've ever tried to describe an ayahuasca vision to a therapist who has no framework for non-ordinary states, you know how quickly the conversation can flatten into something clinical and small. Transpersonal therapy holds space for the material that talk therapy often can't reach. Dreams that feel prophetic. A sudden collapse of identity during meditation. The experience of encountering an ancestor, a plant spirit, or a version of yourself you didn't know existed. A transpersonal therapist doesn't necessarily believe in the literal reality of these experiences — but they also don't dismiss them. They work with what emerged and what it means to you. The other big difference is that the client leads. Rather than imposing a framework from the outside, a transpersonal therapist works within your existing worldview — your spiritual beliefs, your cultural background, your understanding of what healing looks like. If you're an atheist who had a mystical experience on mushrooms, that's the material. If you grew up Catholic and now find yourself drawn to Andean cosmology, that's the material too. Transpersonal therapy isn't one technique — it's a toolkit. Which tools come out depends on the therapist's training and what you actually need. Here's what a session might include: A skilled transpersonal therapist doesn't throw the whole toolkit at you. They read what's alive in the room and pick the practice that fits. Sometimes that's a two-minute body scan. Sometimes it's an hour of drawing whatever wants to come out. Here's where it gets practical. If you're researching an ayahuasca retreat or thinking about psilocybin — for depression, addiction, PTSD, or one of those knotted-up life patterns that won't loosen no matter what you try — the ceremony itself is only half the equation. Maybe less than half. The other half is what happens in the weeks and months afterward. What do you do with the memory of dissolving into the walls of the maloca? How do you translate a vision of your grandmother handing you a key into an actual change in how you show up on Tuesday morning? This is where integration lives, and transpersonal therapy is one of the most useful frameworks for it. Master plants — ayahuasca, San Pedro, iboga, psilocybin — tend to open material that ordinary consciousness has spent years keeping tidy. Ancestral wounds. Buried grief. Addictive patterns that turn out to be protecting something younger and more tender than you realized. A good integration therapist trained in transpersonal work can help you sit with that material long enough to actually metabolize it, rather than filing it under "weird trip experience" and moving on. Addiction is one of the areas where transpersonal approaches quietly shine. Twelve-step programs have always understood something that mainstream medicine took decades to catch up to: recovery from serious addiction often requires a spiritual reorientation, not just behavior change. The current wave of research into psychedelic-assisted therapy for addiction — psilocybin for alcohol use disorder, ibogaine for opioid dependence, ayahuasca for a range of substance issues — tends to work best when paired with the kind of meaning-making that transpersonal therapy is built for. The substance opens the door. The therapy helps you walk through it and stay through it. This is why serious retreat centers put so much emphasis on preparation and aftercare. If a place is only selling you the ceremony, that's a red flag. The ceremony without integration is a fireworks display. The ceremony with real integration support is where the actual healing lives. One of the more important contributions of the transpersonal field is a clearer language around what Stanislav and Christina Grof called spiritual emergence — intense psychospiritual experiences that look, from the outside, uncomfortably close to a psychiatric crisis but are actually part of a growth process. Ego dissolution during a ceremony. Weeks of emotional volatility after a retreat. Sudden shifts in identity, relationships, worldview. These can be genuine markers of transformation. They can also, sometimes, be signs that someone needs medical support. The distinction matters, and it isn't always obvious in the moment. A therapist trained in this territory knows the difference between a difficult but productive dark night of the soul and a genuine mental health emergency. They also know when to refer out. If you're going into ceremony with any history of psychosis, bipolar disorder, or severe dissociation, this is exactly the kind of practitioner you want in your corner — someone who can hold spiritual experience seriously without romanticizing the risks. The field is unregulated in most countries, which means the label alone doesn't guarantee competence. A few things to look for: The evidence base for transpersonal therapy is still catching up to the clinical practice — most of the research lives in adjacent fields like mindfulness research, psychedelic-assisted therapy trials, and IFS studies. But the direction of travel is clear. Mainstream psychology is slowly, awkwardly making room for what transpersonal therapists have been saying for fifty years: that meaning, spirit, and non-ordinary experience are not decorations on top of psychological life. They're part of it. If any of this resonates and you're weighing whether a ceremony or a longer retreat is your next step, the plant-medicine and psychedelic retreats featured on our marketplace can be browsed here. Take your time with the decision — the good ones aren't going anywhere, and the preparation you do before you sit is often what makes the sitting worth doing at all.
Ibogaine at 73: Does Age Really Change the Journey?
A question keeps surfacing in the quieter corners of the plant-medicine world: can someone in their seventies safely sit with ibogaine? It comes up because ibogaine has a growing reputation for interrupting long-standing addictions and shaking loose depression that decades of therapy could not touch. And it comes up because the people asking are often the ones who have run out of other options. I want to answer this carefully. Ibogaine is not ayahuasca. It is not psilocybin. It is its own beast — a long, physically demanding, deeply psychological experience derived from the root bark of the West African iboga shrub. Age matters here in ways it doesn't with softer psychedelics. If you're weighing this decision for yourself or for a parent, here's what actually needs to be on the table. Most conversations about psychedelics and older adults focus on set, setting, and psychological readiness. Those matter. But ibogaine adds a variable the others don't: it directly affects the heart's electrical rhythm. Specifically, it can prolong the QT interval, which in plain language means it makes the heart take slightly longer to reset between beats. For a healthy 30-year-old with a clean cardiogram, that's usually managed with careful dosing and monitoring. For a 73-year-old with any underlying cardiac history, the calculation shifts. This is why reputable ibogaine clinics — and there are only a handful worth trusting — require extensive medical screening before they'll even accept a booking. Bloodwork. ECG. Liver panel. A full medication review. If a clinic doesn't ask for these, that's not a clinic. That's a liability waiting to happen. The tricky part with older adults is that many of the medications commonly prescribed after 60 — SSRIs, beta-blockers, certain heart-rhythm drugs, some pain medications — either interact with ibogaine or independently affect QT interval. Tapering them off safely can take weeks or months, and some can't be stopped safely at all. That's a legitimate reason a clinic might turn someone away, and honestly, it's the kind of gatekeeping you want to see. Setting aside the medical side, the psychological experience of ibogaine at 73 versus 33 is genuinely different, and the difference isn't always what people expect. Younger participants often describe the experience as revelatory — a compressed life review, a confrontation with patterns they hadn't fully seen. Older participants describe something more like a reckoning. They've already lived the patterns. They've already accumulated the losses, the regrets, the roles played too long. Ibogaine doesn't show them who they might become. It shows them who they've been. That can be more sobering, and sometimes more freeing. There's a common thread in what older folks say afterward: a softening around long-held resentments, a re-evaluation of relationships with grown children or estranged siblings, and a distinct sense of what still matters versus what they've been carrying out of habit. One woman in her late sixties described it as “losing thirty years of weight I didn't remember picking up.” That's not a promise — some people find the experience punishing rather than clarifying — but it's a pattern worth noting. Most people arrive at ibogaine because of addiction — often opioids, sometimes alcohol, sometimes both. The medicine's reputation for interrupting opioid dependence with a single session is what put it on the map, and the underlying research is more robust than most psychedelic-adjacent claims. It genuinely does appear to reset receptor activity in ways that reduce withdrawal and craving, at least for a window of weeks or months. For older adults with long addiction histories, this window can be a genuine opening. Someone who has been on methadone for twenty years, or drinking heavily since their thirties, is often skeptical that anything can shift the pattern. Ibogaine sometimes does. But — and this is important — the shift is not the cure. It's the door. Whether someone walks through depends almost entirely on what happens after they leave the clinic. Older adults sometimes have an advantage here: they've often accumulated stability that younger participants lack. A settled home. Grown children. Fewer social pressures to keep drinking or using. When that stability is combined with a genuine ibogaine reset, the outcomes can be remarkable. If you or someone you love is seriously considering an ibogaine retreat later in life, here's the short list of questions worth asking any clinic before wiring a deposit: A clinic that gets defensive about any of these questions is telling you something. A clinic that answers them plainly, admits limitations, and refers out when appropriate is showing you what safe practice looks like. Ibogaine exists in two broad worlds. On one side are the traditional Bwiti ceremonies of Gabon, where iboga has been used for centuries in initiation rites — long, communal, deeply cultural experiences. On the other are medical or semi-medical clinics, mostly in Mexico, Costa Rica, and a few other jurisdictions where ibogaine sits in a legal grey zone. For a 73-year-old, my honest take is that the clinical setting is almost always the right call. The Bwiti tradition is extraordinary and deserves respect, but it wasn't designed around modern cardiovascular risk factors. Iboga in a traditional setting can involve doses and durations that a clinical protocol would never approve for an older participant with any medical complexity. That said, “clinical” doesn't automatically mean “safe.” Some clinics operate with rigorous medical protocols, board-certified physicians, cardiac monitoring, and thoughtful integration. Others operate out of Airbnbs with a nurse on call and a lot of confidence. The gap between these two is enormous, and price is not a reliable indicator of which is which. Do the homework. Ask for references. Look for clinics that have been operating for at least five years and have published protocols. When someone asks whether age changes the ibogaine experience, they're often really asking something else: is it worth the risk at this point in my life? That's a personal calculation nobody outside your situation can make for you. But I'll say this — the people I've spoken with who did ibogaine later in life and came through it well tend to describe it not as a wild adventure but as a long-overdue conversation. With themselves. With the people they've lost. With the parts of their life they were still avoiding. The risks are real. The screening is non-negotiable. The clinic matters more than almost anything else. But the notion that ibogaine is only for the young misses something important about who often benefits most from a hard, honest reckoning with the life they've actually lived. For readers who want to look further, a range of vetted ibogaine and plant-medicine retreats can be browsed on our marketplace here. Whatever you decide, take your time with the decision — this is one where the boring, careful work of choosing well is the whole game.
Ibogaine for Opioid Addiction: What Desperate Readers Actually Need to Know
People don't usually type “ibogaine” into a search bar because they're curious. They type it because they've tried everything else — Suboxone, methadone, rehab twice, maybe three times, cognitive behavioural therapy, twelve steps, a sponsor, a therapist, a partner who's exhausted. And it isn't working. Or it worked for a while and then didn't. That's the reader I want to talk to here. Ibogaine sits in a strange corner of the psychedelics and plant medicines conversation. It isn't festival-friendly. Nobody comes home from an ibogaine week talking about how fun it was. It's rough, it's medically serious, and it's one of the very few substances on Earth with credible evidence for interrupting opioid addiction in a single session. That combination — high stakes, high potential, high risk — is exactly why it deserves a careful, honest look before anyone books a flight. Ibogaine is the primary psychoactive alkaloid in the root bark of the iboga shrub, Tabernanthe iboga, which grows in the forests of Gabon and Cameroon. For centuries it's been used ceremonially by the Bwiti tradition in Central Africa — as a rite of passage, as a way of confronting ancestors, as a medicine for the soul. Western researchers only stumbled onto its anti-addictive properties in the late 20th century, mostly by accident, when heroin users reported their cravings simply gone after taking it. Pharmacologically it's unusual. It acts on multiple receptor systems at once — opioid, serotonergic, NMDA, sigma — which is part of why nobody has fully replicated it with a cleaner synthetic. It also has a long half-life and produces a waking dream state that can last 12 to 24 hours. This isn't a mushroom trip. It's closer to being placed inside your own memory and asked to look, without the option of turning away. The most striking claim about ibogaine — and the one that keeps drawing desperate people toward it — is that a single therapeutic dose can eliminate the acute withdrawal symptoms of opioid dependence and drastically reduce cravings for weeks or months afterward. Small clinical studies out of New Zealand, Mexico, and Brazil have shown remarkable outcomes, though the sample sizes are modest and long-term follow-up varies. What it doesn't do is fix your life. And this is where a lot of first-time seekers get the wrong idea. Ibogaine can hand you a window — a stretch of clarity where the physical grip of the drug is loosened and the psychological patterns underneath become visible. What you do with that window is up to you, your aftercare team, your relationships, and your commitment to the boring, unglamorous work of building a life worth staying sober for. In the United States, ibogaine is a Schedule I substance — the same legal category as heroin, which is a special kind of irony. It's also restricted in France, Belgium, Sweden, and Switzerland. But it's unregulated or legally available in Mexico, Costa Rica, Brazil, Portugal, New Zealand, South Africa, and parts of the Caribbean. That's why nearly every reputable ibogaine treatment centre operates outside the U.S., with Mexico and Costa Rica being the two largest hubs for English-speaking clients. Reputable is the key word. There is no international accreditation body for ibogaine clinics. Anyone can rent a house, buy some bark, and call themselves a facilitator. The difference between a good clinic and a dangerous one is not marketing. It's medical infrastructure. If you're seriously considering ibogaine — for yourself or someone you love — these are the non-negotiables: If a clinic waves away any of the above, walk. The deaths associated with ibogaine — and there have been some — almost universally trace back to skipped screening, undisclosed pre-existing conditions, or unqualified people running the show. Facilitators and past participants describe the ibogaine session in three loose phases. The first, roughly one to four hours in, is the visionary phase — a flood of imagery, memories, sometimes childhood scenes played back with disorienting clarity, sometimes symbolic material that borders on the mythic. Some people describe it as watching a film reel of their life. Others describe conversations with people long dead. Nausea is common. So is a whole-body vibration and extreme sensitivity to sound. The second phase is introspective and quieter — a stretch of hours where the visual content fades and something more like deep review takes over. This is where a lot of the therapeutic work seems to happen. Patterns become visible. Choices become clear. The reason you keep using — the actual reason, not the story you tell your counsellor — sometimes surfaces without warning. The third phase is the long tail: exhaustion, ataxia (you can't really walk), and a kind of luminous fatigue that lasts a day or two. Sleep is difficult for the first night. Appetite returns slowly. Most people describe the following week as feeling scrubbed clean — physically lighter, mentally quieter, cravings absent or dramatically reduced. And then real life resumes. Which is why what happens after matters as much as what happens during. Readers researching plant medicine for addiction often ask how ibogaine compares to ayahuasca or psilocybin. The honest answer is that they do different jobs. Ayahuasca is powerful for emotional and trauma-focused work — the material underneath the addiction — but it doesn't interrupt physical opioid dependence. Psilocybin has strong emerging research for alcohol use disorder and tobacco, and increasingly for depression that co-occurs with addictive patterns, but again, it isn't a detox tool. Ibogaine is the one that seems to physically reset the opioid receptor system. It's blunt where the others are subtle. For someone deep in heroin or fentanyl use, that bluntness may be the entire point. Some people work with ibogaine first to break the physical hold, then use ayahuasca or psilocybin months later to work with what remains — the grief, the shame, the reasons. A legitimate residential ibogaine programme in Mexico or Costa Rica typically runs between $6,000 and $12,000 USD for a week to ten days, and often more for longer or more medicalised stays. That price should include medical screening, the ibogaine session itself, accommodation, meals, and some form of aftercare planning. Cheaper than that and you should be asking hard questions about what's being cut. More expensive doesn't automatically mean better — some of the higher-end clinics are paying for beachfront views, not better medicine. Budget also for travel, time off work, and — this is the one people underestimate — the two to three months after treatment. You will not be at full capacity. You'll be raw. Plan for reduced income, therapy sessions, possibly a sober living arrangement, and the kind of low-stimulation life that lets integration actually take root. Ibogaine is not a cure. It's a tool, and a demanding one. Relapse rates are real — some studies show around a third of participants opioid-free at one year, others considerably lower — and the outcome is heavily shaped by aftercare, community, and whether the underlying reasons for use get addressed. Anyone selling you a one-and-done miracle is either naive or lying. It's also not for everyone. People with significant heart conditions, liver disease, active psychosis, or a history of certain cardiac events should not take ibogaine, full stop. Anyone on SSRIs, tricyclics, or MAOIs will need a supervised taper first. Pregnant women shouldn't go near it. And the desperate mental state that often drives people toward ibogaine is also the state that makes them skip screening steps they shouldn't skip. If a clinic doesn't ask you invasive medical questions, that's a red flag, not a convenience. Read every clinic's website twice. Ask them for the name of the medical director and look that person up. Talk to two or three former clients — reputable clinics will happily connect you. Ask what happens if something goes wrong: what hospital, how far, what protocol. Ask what the aftercare looks like on day three, day thirty, day ninety. If the answers are vague, keep looking. And be honest with yourself about what you actually want. Ibogaine can absolutely change the trajectory of a life. It has, for many people. But it works best for the person who arrives already willing to change, who has support waiting on the other side, who understands that the medicine opens a door — it doesn't walk you through. For readers who want to explore this further, a range of vetted ibogaine and plant-medicine retreats can be browsed on our marketplace here. Take your time with the decision. Something this serious deserves it.
Vitamin C and Glutathione for Recovery: Do They Really Work Better Together?
Here's a question that shows up in gym locker rooms and supplement subreddits with surprising frequency: if antioxidants help the body bounce back from hard workouts, does stacking two of them together get you across the finish line faster? Specifically, vitamin C and glutathione — a pairing that keeps popping up in recovery protocols, in green powders, and in the marketing copy of every second wellness brand. The short answer is that the biology behind pairing them is genuinely interesting. The longer answer is that the human research is still catching up, and anyone selling you a guaranteed edge is getting ahead of what we actually know. Let's sit with what the science does and doesn't say, and what a sensible person training hard might actually do about it. Most people fixate on the workout. The sets, the pace, the personal bests. Recovery gets treated as an afterthought — something you'll get to when you have time. That framing has it backwards. Adaptation happens in the hours and days after training, not during. Skimp on the recovery side and you're basically doing the hard work without collecting the paycheck. Recovery isn't one thing, either. It's a stack of small habits: a walk the day after a hard session, some mobility work, decent sleep, food that gives your tissues something to rebuild with. And yes, antioxidants belong in that conversation too, though not in the way most supplement ads suggest. Here's the nuance a lot of people miss. Exercise creates inflammation and oxidative stress on purpose. You don't actually want to shut that response down — the signal is what triggers your body to adapt and get stronger. What you want is help resolving that inflammation on a reasonable timeline, so you're not still limping into the next session three days later. Glutathione doesn't get the attention that vitamin C does, which is a little unfair given that it's the most abundant antioxidant inside your cells. Your body makes it from three amino acids — cysteine, glutamate, and glycine — and puts it to work everywhere from your liver (where it helps clear compounds you don't want hanging around) to your muscles (where it mops up free radicals produced during hard effort). Glutathione levels naturally dip with age, chronic stress, poor sleep, and — you guessed it — intense training. Which is why athletes and biohackers have been interested in it for years. The catch is that glutathione is famously fussy to supplement. Take a standard capsule and much of it may get broken down before it ever reaches your cells. The delivery form matters a lot, and this is where a lot of the research gets tangled up. Vitamin C and glutathione aren't just two random antioxidants sitting side by side. They're linked. When either one neutralizes a free radical, it gets used up — it flips from an active form to a spent form. And here's the twist: each one can help regenerate the other back to its working state. Vitamin C helps recycle oxidized glutathione. Glutathione returns the favor for vitamin C. Think of it like a tag-team match. When one antioxidant is on the ropes, the other tags in and puts it back into the fight. If you let one of them run low, the whole system starts to lose efficiency. That interdependence is the reason researchers keep suspecting that the pair might produce an additive benefit — one where the whole is more than the sum of the parts. This is where I have to be honest with you: the individual studies are a bit of a mess. On vitamin C, results have swung all over the map. Some trials show reduced markers of oxidative stress and better muscle recovery after hard sessions. Others show basically nothing. The mixed picture likely reflects the usual suspects — different doses, different exercise protocols, different fitness levels in participants, different ways of measuring oxidative stress in the lab. What holds up more consistently is that a daily intake somewhere between 200 milligrams and 1 gram tends to lower oxidative stress markers around intense training. That's the range most nutrition researchers land on. Glutathione tells a similar story with an extra wrinkle. Some studies suggest it can support endurance and reduce fatigue markers. Others show flat results. The bigger problem is that studies have used wildly different delivery methods — oral capsules, sublingual forms, liposomal preparations, IV infusions — and how much actually gets into your cells varies enormously between them. Comparing across studies is like comparing apples to a completely different fruit. Certain patented forms, like Setria glutathione, have clinical data behind them showing they can raise blood glutathione levels when taken orally, which is a real thing that most standard capsules can't claim. Liposomal delivery is another approach that seems to improve absorption. If you're going to bother supplementing, the form is arguably more important than the dose printed on the label. Here's the frustrating part. Given how these two antioxidants share a recycling system, it makes perfect biochemical sense that supplementing both could sustain the system better than either one solo. Researchers agree the logic tracks. But the studies specifically testing the combination in exercising humans? They're thin on the ground. The additive effect is anticipated, not proven. Which means anyone telling you the pairing is a game-changer is running ahead of the evidence. It's a reasonable hypothesis, well-supported by biology, and still waiting for the clinical trials to catch up. That doesn't mean the combination is a bad idea. It just means you should hold it as a promising strategy rather than a settled fact. If you're weighing whether to bother, here's a sensible frame: Recovery is one of those areas where people get pulled toward the shiny new supplement and away from the boring fundamentals. It's worth remembering that the biggest levers — sleep quality, nutrient-dense meals, managing stress outside the gym, actually taking rest days — are also the cheapest and least sexy. No amount of glutathione is going to compensate for six hours of sleep and a diet built around rice cakes and pre-workout. That said, thoughtful supplementation as a top-up to a solid foundation is a reasonable move for people training seriously. Vitamin C and glutathione together might just be one of those pairings that quietly earns its place, even if the definitive trial hasn't landed yet. For those exploring recovery from a broader angle — including the somatic and contemplative practices that support the nervous system alongside physical training — a range of wellness and healing retreats can be browsed on our marketplace here. Sometimes the best recovery tool isn't a capsule at all.
Craving More Stories?
Join our ShopAyahuascaRetreats newsletter for the latest updates on thrilling
destinations and inspirational tales, delivered straight to your inbox!
We value your privacy. Your email address will never be shared or published.
Ibogaine Flood Dose: What Actually Happens During the Journey
The first time someone described a flood dose of ibogaine to me, they used a phrase I've never forgotten: it's like watching your entire life play back on a screen you can't turn off. That's not marketing language. That's the kind of thing people say afterward, usually still a little shaken, usually grateful, usually not in any hurry to do it again soon. Ibogaine sits in a strange corner of the psychedelic world. It doesn't get the press ayahuasca gets. It doesn't have psilocybin's cultural moment. But among people working on addiction — especially opioid addiction — ibogaine has a reputation that borders on legendary. And for good reason. It also carries real risk, which is why most serious conversations about it happen at licensed clinics rather than in someone's living room. If you're researching plant medicines for stuck patterns, trauma, or addiction, and ibogaine keeps surfacing in your searches, this is a walk through what a flood dose actually involves — the ceremony itself, the aftermath, and the things nobody puts on the retreat brochure. Ibogaine comes from the root bark of the Tabernanthe iboga shrub, native to Central Africa, where the Bwiti people have used it in initiation ceremonies for centuries. When it moved into Western therapeutic settings, practitioners developed a few different dosing protocols. A flood dose is the big one. Full immersion. Usually a single large dose calibrated to body weight, given under medical supervision, that produces a psychoactive experience lasting anywhere from 12 to 36 hours. Compare that to a microdose (tiny amounts taken over weeks, mostly used for mood or focus) or a booster protocol (moderate doses spaced across several days). The flood is different in kind, not just degree. It's the version people mean when they say ibogaine reset their addiction, or that it showed them everything they'd been running from. Before the medicine is given, a legitimate provider will run bloodwork and — critically — an EKG. Ibogaine affects the heart's QT interval, and people with certain cardiac conditions genuinely cannot take it safely. This isn't a formality. This is the difference between a life-changing experience and an emergency. People often break the flood into three distinct phases, and while individual experiences vary wildly, the general arc holds up. The visionary phase hits within the first hour or two. This is what most people picture when they hear “psychedelic experience,” but ibogaine's version is unusual. Eyes closed, you tend to see rapid, film-like sequences — memories, symbolic images, sometimes scenes that feel more like watching than participating. There's often a distinctive buzzing sound, an inner tone that some people find unnerving and others find weirdly grounding. Physical sensations include ataxia (movement becomes wobbly and uncoordinated), nausea, and heightened sensitivity to light. Most facilitators ask you to stay lying down for the entire journey. Getting up is genuinely dangerous. The introspective phase settles in over the next several hours. The visual intensity fades and something quieter takes over — a kind of cool, analytical review of your own life. Relationships. Choices. Patterns. People describe it less as remembering and more as seeing, as though a version of themselves they'd been avoiding is finally in the room. It's not always pleasant. But it's often the phase that produces the shifts people credit ibogaine for. The residual phase can stretch for a full day or more. You're exhausted but often can't sleep. The mind keeps working. Thoughts arrive with unusual clarity. This is where much of the integration actually begins, before you've even left the treatment room. The most-cited reason people seek out ibogaine is opioid dependency. There's a phenomenon that's been observed clinically and reported anecdotally for decades: a properly administered flood dose can dramatically reduce or eliminate withdrawal symptoms and cravings for opioids. Not always. Not permanently in every case. But often enough that harm-reduction advocates have been pushing for wider research access for years. The mechanism isn't fully understood, but ibogaine appears to act on multiple receptor systems at once — opioid, serotonergic, glutamatergic — and to promote a kind of neural plasticity that's still being studied. What people report is that the physical grip of the addiction loosens, and the psychological review during the journey often reveals why the addiction had a grip in the first place. Both things at once. That combination is rare in addiction treatment. It's worth naming what ibogaine is not. It's not a cure. It's not a substitute for aftercare, therapy, or community. People who treat it as a one-and-done fix and skip the integration work tend to relapse. People who treat it as a powerful opening move — followed by months of real, unglamorous behavioral change — tend to fare much better. These two get compared constantly, and the comparison is useful because they're genuinely different tools. Neither is better. They answer different questions. Some people benefit from both, spaced far apart with real integration in between. Ibogaine's legal status is uneven. It's Schedule I in the United States but legal or unregulated in Mexico, Costa Rica, Portugal, the Netherlands, and several other countries. This means most people who take ibogaine travel to a clinic abroad. Choosing well matters more here than with almost any other plant medicine, because the medical risks are real. Questions worth asking before you book: Cost varies wildly — anywhere from around $5,000 to $10,000+ for a proper medical program. Cheaper isn't better here. The screening and monitoring are what keeps ibogaine safe, and skimping on either is where things go badly wrong. People often ask what the days and weeks after a flood dose feel like. The most common answer: quiet, tired, tender, and unusually clear. There's a well-known window — sometimes called the afterglow, sometimes the reset — where the mind feels reorganized and the old cravings or compulsions are noticeably weaker. This window is a gift and also a trap. If you use it to build new habits, seek out therapy, repair relationships, and change your environment, the shift can hold. If you don't, the old patterns reassert themselves. Ibogaine gives you a door. It doesn't walk you through it. Integration matters more than the ceremony. That's true of every plant medicine, but with ibogaine it's especially blunt. The people who report the best long-term outcomes tend to share three things: they had strong pre-treatment intentions, they took the aftercare period seriously, and they made structural changes in their lives — not just internal shifts. If any of this speaks to something you've been sitting with, ibogaine and adjacent plant-medicine retreats can be browsed on our marketplace here. Take your time with the decision. This isn't a weekend workshop, and the people who go in prepared are usually the ones who come out changed.
Six Common Food Preservatives Linked to Cancer in a Massive 14-Year Study
Flip over almost anything in your pantry and the ingredient list starts to read like a mid-tier chemistry exam. Potassium sorbate. Sodium metabisulfite. Sodium erythorbate. These are the invisible workhorses keeping bread mold-free, deli meat pink, and cheese edible three weeks after you forgot about it in the drawer. We've mostly shrugged and accepted them as the tax on modern grocery shopping. But here's a question worth sitting with: are all of these additives really the same? We tend to file them into one big mental folder marked probably fine, probably not great, without distinguishing between compounds that are genuinely benign and ones that might quietly be doing something we'd rather they didn't. A recently published 14-year study — one of the largest of its kind — tried to answer that question with actual numbers. Researchers tracked more than 105,000 adults, cataloguing their intake of 17 specific food preservatives, and then followed what happened to their health over time. The findings are worth paying attention to, especially if you're someone who cares about long-term wellbeing and the choices that quietly shape it. The data came from the French NutriNet-Santé cohort, a long-running dietary health project that has been collecting information from participants since 2009. What sets this analysis apart from most nutrition research is the granularity. Participants didn't just record “bread” or “yogurt.” They logged specific brands, across multiple 24-hour dietary recalls, over years. That level of detail matters more than it sounds. Preservative content varies wildly between two products that look identical on the shelf. One loaf of sandwich bread might contain potassium sorbate. The one next to it might use nothing but flour, water, salt, and yeast. Without brand-specific tracking, you're essentially guessing at exposure. The research team cross-referenced these food diaries against composition databases and even ran their own lab tests on frequently consumed items to pin down cumulative intake as accurately as possible. Then they tracked cancer diagnoses over an average follow-up of 7.5 years, adjusting for the usual suspects — age, sex, education, smoking, alcohol, physical activity, family history, and overall diet quality — so the results couldn't easily be explained away by lifestyle differences. Most of the 17 additives studied didn't show a meaningful signal. But six of them did, and the associations were significant enough that the researchers flagged them explicitly: None of this proves causation. Observational studies never do. But the size of the cohort, the length of the follow-up, and the care taken with brand-level data give the findings more weight than the average nutrition headline. The researchers proposed a few possible biological mechanisms: certain preservatives may nudge inflammatory or immune pathways in unhelpful directions, promote the formation of carcinogenic compounds in the body, or disrupt the gut microbiome in ways that ripple outward. All plausible. None yet nailed down. Before anyone starts panicking and tossing every packaged item into the bin — don't. That's not what this research asks of you. A single bar of chocolate with sulfites in it is not going to determine your health trajectory. The story here is about cumulative exposure over years, not any single meal. Still, there are some sensible moves worth considering: There's something worth naming here that goes beyond the specifics of any one preservative. A lot of us are quietly aware that the modern food environment isn't doing us any favors, and yet we push that awareness down because it feels overwhelming to act on. Studies like this one make it harder to keep pushing it down, which is uncomfortable — but probably useful. People who spend time in retreat settings, plant-medicine work, or serious contemplative practice often report a shifted relationship with food afterward. Not through some mystical download, but because sustained attention to the body tends to make you notice what it actually feels like to eat certain things. The bloating. The energy crash. The strange fatigue after a highly processed meal. Many people leave these experiences quietly rearranging their pantry without anyone telling them to. You don't need a ceremony to make the same choices. But the underlying principle — pay attention to what you're putting in, and to what your body says back — is the same either way. This study is one of the more careful looks at preservatives and long-term cancer risk to date. It doesn't say every additive is dangerous. It doesn't say packaged food is poison. What it does say is that not all preservatives are equal, and a handful of them show consistent enough associations with cancer risk to warrant paying attention. Being thoughtful about which additives show up most often in your week is a modest, doable step. It costs nothing. It doesn't require an overhaul. It just requires flipping the package over now and then and making a slightly different choice when it's easy to do so. For readers who find that questions about the body, food, and long-term health lead them toward deeper self-inquiry, a range of plant-medicine and wellness retreats supporting that kind of reset can be browsed on our marketplace here. The path to feeling better is usually made of small choices repeated for years, and sometimes a longer pause to reset the whole system. Both count.
Meditation Saved My Life: What That Phrase Actually Means
You hear it in recovery meetings, in yoga studios, in the quiet minutes after a ceremony winds down. Meditation saved my life. It sounds dramatic until you meet the people who say it — and then it doesn't sound dramatic at all. It sounds like a plain description of what happened. I've spent years around people navigating addiction, depression, and the aftermath of plant-medicine work, and the pattern is consistent: those who build a daily sitting practice tend to hold onto their gains. Those who don't often lose them. That's not a slogan. It's what actually happens when the ceremony ends and Tuesday morning arrives. When someone says meditation saved their life, they usually don't mean they were levitating in bliss. They mean something more practical. They mean that at 3 a.m., when the old thought showed up — the one that used to drive them to a bottle, a bridge, a bad relationship — they were able to notice it as a thought instead of obeying it. That gap, sometimes only a second wide, is where lives get rerouted. For people coming out of ayahuasca, ibogaine, or psilocybin work, that gap matters even more. Psychedelics can crack something open. They can show you, in searing color, what your patterns look like from the outside. But the medicine doesn't come home with you. Your nervous system does. And a nervous system that hasn't learned how to sit with discomfort will keep looking for the exit. Meditation, done consistently, is training in not needing the exit. It's a slow rewiring — not glamorous, occasionally boring, sometimes deeply uncomfortable. And for a certain kind of person, it becomes the thing that turns temporary breakthroughs into permanent shifts. Anyone who's sat in ayahuasca ceremony has probably noticed how much the experience resembles a very intense meditation. The visuals, the memories, the body sensations — they all rise and pass. The instruction from the shamans is often nearly identical to what a Zen teacher would say: don't grab, don't push away, just breathe and stay with it. This isn't coincidence. Master plants and contemplative traditions are both, at their core, technologies for meeting your own mind. One works in hours; the other works in years. Both point at the same thing. Where they differ is durability. A single ceremony can produce a shift so profound that people describe it as a rebirth. But without integration — without a daily practice that keeps the channel open — that shift can fade. Six months later, the person is back to old patterns, wondering what happened. This is the great unspoken problem in the psychedelic healing space. The medicine works. The follow-through doesn't always. Meditation is one of the few practices that reliably bridges that gap. It doesn't compete with the medicine. It carries it. Let me be honest about what beginning meditation looks like, because most articles skip this part. The first two weeks are usually awful. Your knees hurt. Your mind won't shut up. You're convinced you're doing it wrong. You are not doing it wrong. This is what it looks like. Somewhere around week three or four, something shifts. Not enlightenment. Just a small noticing. You catch yourself mid-spiral and think, huh, there I go again. That noticing is the whole thing. That's the muscle you're building. None of this is mystical. It's cognitive skill-building with your eyes closed. But the effects compound in ways that surprise people. Sleep improves. Reactivity drops. You start to like your own company again. For someone climbing out of addiction or depression, these small wins are load-bearing. If you're considering an ayahuasca retreat, an ibogaine program, or any serious psychedelic work for addiction or trauma, here's the piece nobody at the intake call will emphasize enough: your integration practice matters more than the ceremony itself. Integration means taking what you saw and turning it into how you live. That process is largely internal. You have to be able to sit with yourself long enough to hear what the medicine was trying to say. Without a contemplative anchor, most people talk about their experience for a while, then quietly drift back to baseline. The insights don't stick because there's no place in the nervous system for them to land. A meditation practice — even a modest one, twenty minutes a day — gives those insights somewhere to go. It builds the kind of interior stillness that lets the deeper messages surface at their own pace, sometimes weeks or months after the ceremony ended. Practical starting points for anyone preparing for or returning from a plant-medicine retreat: Addiction, at its core, is an inability to be present with painful internal states. Whatever the substance or behavior — alcohol, opioids, food, sex, work — the mechanism is the same. Something inside becomes unbearable, and the compulsion arrives to make it stop. Ibogaine and ayahuasca have both shown remarkable results in interrupting that mechanism. They can reset the reward system, surface the buried trauma, and offer a felt sense of being okay that many addicts have never experienced. But the pull of the old patterns is patient. It waits. And in the months following a ceremony, when the medicine's glow fades and life resumes its ordinary difficulty, that pull comes back. This is where meditation stops being optional. Sitting practice teaches the same lesson the medicine taught — that unbearable feelings are not, in fact, unbearable — but it teaches it slowly, in your own living room, on your own schedule, with no facilitator required. It gives you a way to keep the door open. People who combine both — a genuine plant-medicine experience with a real contemplative practice afterward — tend to be the ones who make it through. Not because meditation is magic, but because it makes the magic sustainable. You don't need a cushion, an app, or a retreat to begin. You need a chair, a timer, and the willingness to be a little uncomfortable for a few minutes each day. That's it. Everything else is decoration. Some days it'll feel pointless. Some days you'll skip. Fine. The practice is coming back the next day anyway. That's the practice. And if you're weighing a plant-medicine retreat as part of your own healing — for addiction, depression, or something you can't quite name — know that the ceremony is only half the work. The other half happens in the ordinary hours, in silence, alone with your own breath. For readers curious about pairing that inner work with a supported ceremonial container, a range of ayahuasca and plant-medicine retreats can be browsed on our marketplace here. Meditation didn't save anyone's life in a single dramatic moment. It saved them one Tuesday at a time, one breath at a time, until enough Tuesdays had passed that a different life was quietly already underway.
Psychedelic Industry Update: What SAMHSA, Compass, and Ibogaine Deals Mean for Retreat-Seekers
If you spend any time reading about psychedelic medicine — really reading, not just doom-scrolling headlines — you already know the field moves in strange rhythms. Quiet for months. Then a week arrives where three separate stories break at once and suddenly the whole picture shifts. This past week was one of those. Federal agencies convened experts to figure out what they don't know about psychedelic use in America. A major biotech signaled its endgame. An ibogaine developer got courted by Big Pharma. And one veteran researcher is quietly betting his career on a version of LSD that doesn't get you high. If you're weighing an ayahuasca retreat, considering ibogaine for addiction, or just trying to understand where legal access is heading, this stuff matters — even when it sounds like inside baseball. Let me walk you through what happened and, more importantly, what it means for the person on the other side of the screen who's actually thinking about sitting in ceremony. Dozens of experts gathered in Washington last week under a mouthful of a title: Addressing Data Gaps to Monitor the Expanding Use and Misuse of Psychedelics in the U.S. Federal officials, state regulators, researchers, and a few entrepreneurs sat down for two days to compare notes. Drug-development companies, notably, weren't invited — which tells you something about the room's mood. Here's the honest translation: the government has no clear picture of how many Americans are using psychedelics, in what contexts, with what outcomes, and where the harms are landing. Ceremonial use, underground guides, Oregon's regulated psilocybin services, Colorado's healing centers, ketamine clinics, the growing crowd of people flying to Peru or Mexico for ayahuasca and ibogaine — it all shows up in scattered data, if it shows up at all. Why should you care? Because policy follows data. When agencies can point to real numbers about who benefits and who gets hurt, licensed access expands. When they can't, the field stays a patchwork of expensive gray-market options and a handful of state programs. If you're waiting for legal, insurance-covered psychedelic therapy in your city, this consultation is a small brick in a long wall. Progress is happening. It's just molasses-slow. Compass Pathways — the London-headquartered company developing a synthetic psilocybin therapy — has been talking openly about expanding beyond treatment-resistant depression into other indications. On its most recent earnings call, executives raised the possibility of tapping the Department of Veterans Affairs as a partner in reaching more patients faster. The VA angle is interesting. Veterans are one of the most vocal constituencies pushing for psychedelic access, and internal VA studies of MDMA and psilocybin for PTSD have quietly moved forward for years. If the VA becomes a formal launch partner for a psilocybin therapy, hundreds of thousands of veterans could gain access without waiting for state-by-state rollouts. For the retreat-considering reader, the takeaway is this: the medicalized version of psilocybin therapy is inching toward reality, but the timeline is still measured in years, not months. If you're suffering now and researching a retreat as a legitimate path, you're not being impatient. You're being realistic about how long the clinical route takes. One of the more consequential stories came out of the ibogaine world. AtaiBeckley, the merged psychedelic developer, is reportedly navigating a courtship with Eli Lilly — the pharmaceutical giant — around its ibogaine analog program. There's talk of licensing carve-outs, counteroffers, and the kind of dealmaking that suggests a real product could reach late-stage trials with serious backing. Ibogaine deserves your attention if you or someone you love is struggling with opioid addiction. The unmodified molecule, derived from the West African iboga shrub, has been used ceremonially for centuries and studied semi-formally for decades. Anecdotal reports and small trials point to something remarkable: a single ibogaine session can dramatically reduce or eliminate opioid withdrawal and cravings, sometimes for months. The catch is that ibogaine carries genuine cardiac risk and demands medical supervision. If a company like Lilly ends up behind a safer, standardized ibogaine analog, we're looking at a future where a version of this treatment sits inside hospitals and clinics, covered by insurance, with cardiologists in the next room. That future is probably five to ten years out. In the meantime, people who need help now are traveling to Mexico, Costa Rica, and Portugal for supervised ibogaine treatment at licensed clinics — a route that requires careful vetting but is a real option. Here's the weirdest and, in some ways, most interesting thread. Matthias Turnbull is doubling down on BOL-148, a brominated LSD analog that appears to retain therapeutic effects without producing a hallucinogenic experience. Yes, you read that right — LSD without the trip. The pitch is straightforward: if the antidepressant, anti-addictive, or anti-cluster-headache effects of psychedelics come from neuroplasticity mechanisms rather than the subjective experience itself, then a non-hallucinogenic version could be prescribed like any other medication. No eight-hour session. No trained facilitator. No integration therapist. Just a pill. The psychedelic community is split on this. One camp cheers the accessibility. Another argues — with real philosophical weight — that the healing is the experience. The insight, the confrontation with self, the felt sense of something larger. Strip that away and you might have a decent SSRI alternative, but you don't have plant medicine in any meaningful sense. My honest take: both things can be true. There will likely be a lane for pharmaceutical, non-hallucinogenic derivatives aimed at people who want a medication, and a separate lane for full-experience work aimed at people seeking transformation. Retreats and ceremonies live firmly in the second lane, and they aren't going anywhere. Industry news is easy to get lost in. So let's pull the thread back to the reader who came here because they're actually weighing a decision — Peru, Costa Rica, a Colorado healing center, a psilocybin retreat in Jamaica, ibogaine in Mexico. A few practical observations from watching this space for a while: A closing thought. The psychedelic industry generates a lot of noise — earnings calls, regulatory filings, celebrity endorsements, breathless podcasts. Most of it doesn't matter to your decision. What matters is more boring and more personal: Are you clear on why you want to do this? Do you have someone in your life to help you integrate afterward? Is the retreat you're considering run by facilitators with real lineage or real clinical training? Do they screen for medical and psychological contraindications, or do they take anyone with a credit card? Those questions will still be the right ones whether SAMHSA gets its data, whether Lilly buys the ibogaine program, or whether BOL-148 becomes a household name in 2031. The industry will keep moving. Your work stays yours. If you're at the point where reading updates like this feels less like curiosity and more like preparation, that's usually a signal worth listening to. A curated range of ayahuasca, psilocybin, and ibogaine retreats can be browsed on our marketplace here, if you'd like to see what's actually available while the policy world sorts itself out.
Should You Chase Muscle Soreness After a Workout? What the Science Actually Says
There was a stretch of years where I judged every workout by how hard it was to walk down stairs the next morning. Legs quivering on the way to the coffee machine? Great session. Struggling to lift my arms in the shower? Even better. Wake up feeling fine? Clearly I'd wasted an hour of my life. Turns out I had it backwards. Not slightly — completely. The idea that muscle soreness equals muscle growth is one of the stickiest myths in fitness, and it's cost a lot of well-meaning people a lot of unnecessary suffering. It's the reason gym memes keep celebrating the inability to sit on a toilet after leg day. It's the reason phrases like “no pain, no gain” still get shouted at 6 a.m. bootcamps. And it's almost entirely wrong. Here's what soreness is actually telling you, what it isn't, and what to pay attention to instead if you want to get stronger without wrecking yourself twice a week. Muscle soreness feels satisfying for the same reason a receipt feels satisfying. It's proof. Something happened. You did a thing, your body responded, and now you have a physical reminder of the effort every time you sit down. The problem is that muscle growth is slow, quiet, and boring. A new pound of lean tissue doesn't announce itself. A slightly better squat pattern doesn't send you a text message. So we grab whatever short-term signal we can — and soreness is right there, loud and obvious, the morning after. The technical name for that ache is delayed onset muscle soreness, or DOMS. It usually shows up 12 to 24 hours after training, peaks somewhere between one and three days later, then fades. It comes from tiny amounts of damage to muscle fibres and the connective tissue around them, followed by an inflammatory response as your body patches things up. That inflammation is what makes the area tender. Yes, something is happening in there. It's just not necessarily the something you want. Notice how the first workout after a two-week holiday leaves you crippled, even if it wasn't especially hard? Or how one Pilates class after years of lifting makes muscles you didn't know you owned throw a tantrum? That's not because those sessions were more effective. It's because they were new. Your body responds most dramatically to unfamiliar stimulus. New angles, new ranges of motion, new tempos, new implements — all of these produce more of the mechanical stress that drives DOMS. Once your body has seen a movement a few times, it adapts. The next round of the same workout barely leaves a mark. Researchers call this the repeated bout effect, and it explains why elite lifters can hit the same fundamental lifts for a decade without waking up sore most weeks. Think about what that means. If soreness genuinely tracked with muscle growth, you'd need to reinvent your program every seven days just to keep progressing. Nobody who actually gets strong trains that way. The people who put on real muscle repeat the same handful of movements, week after week, month after month, and get slightly better at them. The short answer is mechanical tension. When a muscle is asked to produce meaningful force against resistance — especially when you train close to the point where you couldn't do another clean rep — you send a signal to your body that says, roughly, we need to be able to do this more easily next time. Your body responds by getting stronger and, over months, larger. Notice what's missing from that description. Soreness. Exhaustion. The feeling of being flattened. None of them are prerequisites. They can happen alongside effective training, sure. But they aren't the mechanism. In fact, if you're constantly sore, you're probably training less often than you should be. Most of the research on hypertrophy points toward hitting each muscle group roughly twice a week for optimal growth. If Monday's leg session has you limping through Thursday, you're either skipping Thursday's session or dragging yourself through it at half capacity. Both slow you down. Mild soreness after ramping up your volume, adding a new exercise, or coming back from time off is completely normal. That's not what I'm arguing against. What I'm arguing against is the mindset that makes soreness the goal. Chasing that destroyed feeling tends to push people into a specific set of bad habits: Ironically, all of these habits will make you slower to build muscle, not faster. Your muscles don't grow while you're under the barbell. They grow in the hours and days after, during recovery. Sabotage the recovery and you sabotage the whole project. If soreness is a lousy measuring stick, what should you actually pay attention to? Try any of these: Any one of these tells you more than a sore hamstring ever will. Together, they paint a real picture of whether your program is working. Occasionally, soreness does deserve your attention — but not in the way most people think. Ease off or reassess your training if the ache: Those signs point toward too much volume, not enough recovery, sloppy technique, or an actual injury — not garden-variety DOMS. Remember too that recovery isn't only about rest days. Sleep, protein, hydration, and stress all quietly determine how well you bounce back between sessions. Undersleep for a week and even your good workouts will feel like disasters. Here's the reframe that took me embarrassingly long to accept: the best workout isn't the one that leaves you face-down on the couch. It's the one you can recover from well enough to repeat two days later, and again the day after that, for years. That doesn't mean sessions should feel easy. Progressive overload — gradually asking your body to do a bit more than it did last time — still requires real effort. But there's a meaningful difference between training hard and training so hard you compromise tomorrow. Consistency, over time, beats intensity every time. Small improvements compounded across months and years are what quietly build the strongest, most capable bodies. So the next time you finish a workout and don't feel wrecked, resist the urge to assume you slacked. Ask instead whether you're getting stronger, recovering well, and still showing up. If the answer is yes to all three, you're doing better than most people who spend their weeks limping around as proof of effort. Strength training pairs well with broader recovery and wellness practices — breathwork, mindful movement, deep rest — and for readers looking to weave those into a dedicated reset, a range of health and wellness retreats can be browsed on our marketplace here. The workouts that build the strongest bodies aren't the ones that hurt the most tomorrow. They're the ones you keep coming back to.
Dreaming of a Psychedelic Retreat?
We have the best deals and offers from thousands of organizers all over the world! Get them into your mailbox every week!
We value your privacy. Your email address will never be shared or published.
